Administration of the dopamine agonist bromocriptine (2.5 mg three times a day for 4 days) suppressed (P less than 0.01) mean 24-h plasma 18-OHB levels from 21.9 +/- 2.0 to 14.8 +/- 1.4 ng/dl.
